跳至主要内容
临床试验/EUCTR2021-001976-40-NL
EUCTR2021-001976-40-NL进行中(未招募)1 期

Monitoring immunogenicity of SARS-Cov-2 vaccination in Dutch middle-aged and older individuals(participating in the Doetinchem Cohort Study) - VIDO

ational Institute for Public Health and the Environment0 个研究点目标入组 1,700 人开始时间: 2021年5月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Having participated in round 6 of the Doetinchem Cohort study or living in a nursing home
  • Willing to receive the SARS-CoV-2 vaccine or received the vaccinations not longer than 1 month in advance for the DC participants or no longer than 7 months ago for nursing home residents.
  • Willing to sign the Informed Consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 325
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1375

排除标准

  • Participant of the DC already received their second SARS-CoV-2 vaccination more than 1 month before signing the ICF, so sampling at T2 and further is not possible.
  • Participants living in a nursing home already received both primary SARS-CoV-2 vaccinations more than 7 months before signing ICF.
  • Incapacitated participants

研究者

发起方
ational Institute for Public Health and the Environment

相似试验